MedPath

Clioquinol

Generic Name
Clioquinol
Brand Names
Locacorten Vioform
Drug Type
Small Molecule
Chemical Formula
C9H5ClINO
CAS Number
130-26-7
Unique Ingredient Identifier
7BHQ856EJ5

Overview

Clioquinol was withdrawn in 1983 due to neurotoxicity.

Indication

Used as a topical antifungal treatment.

Associated Conditions

  • Acne
  • Atopic Dermatitis
  • Contact Dermatitis
  • Dermatosis
  • Eczema impetiginous
  • Eczema of the nuchal nape of the neck
  • Folliculitis
  • Fungal ear infection caused by Aspergillus niger
  • Infantile Eczema
  • Inflammation
  • Intertrigo
  • Lichen simplex chronicus
  • Moniliasis
  • Nummular Dermatitis
  • Otitis Externa
  • Pruritis of the scroti
  • Pruritus Ani
  • Pruritus Vulvae
  • Pyoderma
  • Stasis dermatitis
  • Tinea Capitis
  • Tinea Corporis
  • Tinea Cruris
  • Tinea Pedis
  • Bacterial skin infections
  • Chronic otitis externa
  • Corticosteroid-responsive dermatoses
  • Disseminated Neurodermatitis
  • Localized Neurodermatitis

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
HYDRODERM-C CREAM 1%
SIN08790P
CREAM
3% w/w
7/3/1996
DERMANOL-C CREAM 0.1%
SIN08795P
CREAM
3% w/w
7/3/1996
DERMANOL-C CREAM 0.05%
SIN08796P
CREAM
3% w/w
7/3/1996
DERMANOL-C CREAM 0.025%
SIN08793P
CREAM
3% w/w
7/3/1996

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
Locacorten-Vioform Ear Drops
11040
Medicine
A
8/2/1991

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
LOCACORTEN VIOFORM
Endo Operations Ltd.
00074462
Cream - Topical
3 % / W/W
12/31/1968
NEO VAGEX
neolab inc
00147591
Tablet - Vaginal
50 MG
12/31/1964
TRUE TEST
02271885
Patch - Topical
0.08 MG
3/16/2006
VIOFORM HYDROCORTISONE MILD
novartis pharmaceuticals canada inc
00074489
Cream - Topical
3 %
12/31/1961
VIOFORM 3%
novartis pharmaceuticals canada inc
00005142
Cream - Topical
3 %
12/31/1951
VIOFORM + HYDROCORTISONE
ciba pharmaceuticals, ciba-geigy canada ltd.
00074527
Ointment - Topical
3 %
12/31/1959
VIOFORM 3%
novartis pharmaceuticals canada inc
00005797
Ointment - Topical
3 %
12/31/1910
PHENORIS ONT
e l stickley and co ltd.
00428078
Ointment - Topical
2 %
12/31/1978
ARISTOFORM R CRM 0.1%
lederle cyanamid canada inc.
00128058
Cream - Topical
30 MG / G
12/31/1966
VIOFORM HYDROCORTISONE
Endo Operations Ltd.
00074500
Cream - Topical
3 % / W/W
12/31/1957

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
TRUTEST 36 APOSITO ADHESIVO PARA PRUEBA DE PROVOCACION CON ALERGENOS
85395
APÓSITO ADHESIVO PARA PRUEBA DE PROVOCACIÓN CON ALERGENOS
Medicamento Sujeto A Prescripción Médica
Commercialized
MENADERM CLIO 0,25 mg/30 mg/g CREMA
Laboratorios Menarini S.A.
52444
CREMA
Medicamento Sujeto A Prescripción Médica
Commercialized
EPITEST 24 APOSITO ADHESIVO PARA PRUEBA DE PROVOCACION CON ALERGENOS
81160
APÓSITO ADHESIVO PARA PRUEBA DE PROVOCACIÓN CON ALERGENOS
Medicamento Sujeto A Prescripción Médica
Not Commercialized
MENADERM OTOLOGICO 0,25 mg/10 mg/ml gotas oticas en solucion
Laboratorios Menarini S.A.
54860
GOTAS ÓTICAS EN SOLUCIÓN
Medicamento Sujeto A Prescripción Médica
Commercialized
CUATROCREM CREMA
Galenicum Derma S.L.U.
51784
CREMA
Medicamento Sujeto A Prescripción Médica
Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.